immunotherapy

Novartis, Harvard team up to develop immunotherapy drug-delivery systems
Novartis, Harvard team up to develop immunotherapy drug-delivery systems
Drug Delivery Business News
Novartis
Harvard
immunotherapy
drug delivery
R&D
immuno-oncology
Flag link:
An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D
An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D
Endpoints
immunotherapy
psoriasis
Escalier
R&D
Flag link:
Inovio lands $23m in collab with ApolloBio for HPV immunotherapy
Inovio lands $23m in collab with ApolloBio for HPV immunotherapy
Drug Delivery Business News
Inovio
ApolloBio
HPV
immunotherapy
Flag link:
Nanotech, immunotherapy combo vaccinates mouse against cancer
Nanotech, immunotherapy combo vaccinates mouse against cancer
Drug Delivery Business News
nanotech
immunotherapy
vaccines
cancer
Flag link:
Making the Promise of Immunotherapeutics into Reality
Making the Promise of Immunotherapeutics into Reality
Elsevier
immunotherapy
cancer
Flag link:
Despite hype, still much to uncover about immunotherapy
Despite hype, still much to uncover about immunotherapy
BioPharma Dive
immunotherapy
immuno-oncology
Novartis
Flag link:
Drug for Dust Mite Allergy Approved by FDA
Drug for Dust Mite Allergy Approved by FDA
Xtalks
dust mites
allergies
immunotherapy
Odactra
FDA
Merck
Flag link:
Immunotherapy is complicating clinical trial designs
Immunotherapy is complicating clinical trial designs
Stat/Pharmalot
immunotherapy
clinical trials
Flag link:
MRK: How Merck's Stock Price Rose 31.42% in 6 Months
MRK: How Merck's Stock Price Rose 31.42% in 6 Months
Investopedia
Merck
diabetes
immunotherapy
Opdivo
Bristol-Myers Squibb
Keytruda
Flag link:
Bristol-Myers buys Swedish company with immunotherapy treatment
Bristol-Myers buys Swedish company with immunotherapy treatment
Marketwatch
Bristol-Myers Squibb
M&A
Sweden
immunotherapy
Cormorant
HuMax-IL8
Flag link:
Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration
Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration
Yahoo
Adaptimmune
GSK
immunotherapy
Flag link:
Juno Acquires Harvard Spinout, AbVitro, For $125M To Discover More Cancer Immunotherapies
Juno Acquires Harvard Spinout, AbVitro, For $125M To Discover More Cancer Immunotherapies
Forbes
Juno Therapeutics
AbVitro
M&A
immunotherapy
Flag link:
Roche's star immunotherapy posts positive results in bladder cancer
Roche's star immunotherapy posts positive results in bladder cancer
Fierce Biotech
Roche
immunotherapy
bladder cancer
atezolizumab
Flag link:
The Path Is Clear for a New Immunotherapy Entrant
The Path Is Clear for a New Immunotherapy Entrant
Motley Fool
immunotherapy
avelumab
Merck KGaA
Pfizer
Flag link:
How Roche is applying immunotherapy techniques to fight bacterial infections
How Roche is applying immunotherapy techniques to fight bacterial infections
BioPharma Dive
Roche
immunotherapy
antibody–antibiotic conjugate
antibiotics
Flag link:
Not just cancer: Seattle biotechs, researchers explore immunotherapy for other diseases
Not just cancer: Seattle biotechs, researchers explore immunotherapy for other diseases
Bizjournals.com
Seattle
cancer
immunotherapy
Juno Therapeutics
Flag link:
Ichor, J&J to collaborate in $85M hep B immunotherapy deal
Ichor, J&J to collaborate in $85M hep B immunotherapy deal
BioPharma Dive
Ichor
JNJ
hepatitis B
immunotherapy
Flag link:
TapImmune's CEO Says Company Is Preparing "A Very Deep Pipeline in Multiple Indications" for Phase II Trials
TapImmune's CEO Says Company Is Preparing "A Very Deep Pipeline in Multiple Indications" for Phase II Trials
Yahoo
TapImmune
immunotherapy
Flag link:
Lilly to Pair With Merck, Bristol on Cancer Drug Trials
Lilly to Pair With Merck, Bristol on Cancer Drug Trials
WSJ Online
Eli Lilly
Merck
Bristol-Myers Squibb
immunotherapy
clinical trials
Flag link:
2015 an "important year" for Pfizer's IO pipeline, analysts say
2015 an "important year" for Pfizer's IO pipeline, analysts say
Medical Marketing and Media
Pfizer
immunotherapy
Flag link:

Pages